HER2-positive Biliary Tract Cancer
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18411 | Anbenitamab | 2 | Not Yet Recruiting | 1 |
DB17446 | Erfonrilimab | 2 | Not Yet Recruiting | 1 |
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB18411 | Anbenitamab | 2 | Not Yet Recruiting | 1 |
DB17446 | Erfonrilimab | 2 | Not Yet Recruiting | 1 |